Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

KODAK FILM COLOR DEVELOPER PART B PROCESS E-6

NFPA

PRODUCT USE

Part B of a developer for use in colour film processing by the Kodak E6 process.

SYNONYMS

"Color Developer, Process E-6, Part B", "Color Developer, Process E-6, Part B", "KAN
464563", "PCD 5161", "KODAK Colour Developer, Process E-6, Part B", "KODAK Colour
Developer, Process E-6, Part B"

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

Causes burns.
Risk of serious damage to eyes.
May cause SENSITIZATION by skin contact.
Toxic to aquatic organisms, may cause long- term adverse effects in the aquatic
environment.

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  The material can produce chemical burns within the oral cavity and gastrointestinal tract following ingestion.  Considered an unlikely route of entry in commercial/industrial environments.  

EYE

  The material can produce chemical burns to the eye following direct contact. Vapors or mists may be extremely irritating.  If applied to the eyes, this material causes severe eye damage.  The material may produce moderate eye irritation leading to inflammation. Repeated or prolonged exposure to irritants may produce conjunctivitis.  

SKIN

  The material can produce chemical burns following direct contactwith the skin.  The material may cause skin irritation after prolonged or repeated exposure and may produce on contact skin redness, swelling, the production of vesicles, scaling and thickening of the skin.  

INHALED

  If inhaled, this material can irritate the throat andlungs of some persons.  The vapor/mist may be highly irritating to the upper respiratory tract and lungs; the response may be severe enough to produce bronchitis and pulmonary edema. Possible neurological symptoms arising from isocyanate exposure include headache, insomnia, euphoria, ataxia, anxiety neurosis, depression and paranoia. Gastrointestinal disturbances are characterized by nausea and vomiting. Pulmonary sensitization may produce asthmatic reactions ranging from minor breathing difficulties to severe allergic attacks; this may occur following a single acute exposure or may develop without warning for several hours after exposure. Sensitized people can react to very low doses, and should not be allowed to work in situations allowing exposure to this material. Continued exposure of sensitized persons may lead to possible long term respiratory impairment.Inhalation hazard is increased at higher temperatures.  The material may produce respiratory tract irritation, and result in damage to the lung including reduced lung function.  

CHRONIC HEALTH EFFECTS

  Skin contact with the material is more likely to cause a sensitization reaction in some persons compared to the general population.  

  Principal routes of exposure are usually by skin contact/absorption, eye contact and inhalation of vapor/spray mist.  Volatile amine vapors produce irritation and inflammation of the skin. Direct contact can cause burns. They may be absorbed through the skin and cause similar effects to swallowing, leading to death. The skin may exhibit whiteness, redness and wheals.  Inhalation of amine vapors may cause irritation of the mucous membrane of the nose and throat, and lung irritation with respiratory distress and cough. Swelling and inflammation of the respiratory tract is seen in serious cases; with headache, nausea, faintness and anxiety There may also be wheezing.  Sulphur dioxide gas is liberated from the concentrate.  Sulphur dioxide gas in low concentrations can cause respiratory tract  irritation.